Discussion on medication rules of national Chinese medicine master NAN Zheng in treating diabetic kidney disease of qi and yin deficiency and blood stasis syndrome based on data mining
|更新时间:2023-06-16
|
Discussion on medication rules of national Chinese medicine master NAN Zheng in treating diabetic kidney disease of qi and yin deficiency and blood stasis syndrome based on data mining
Beijing Journal of Traditional Chinese MedicineVol. 41, Issue 9, Pages: 1053-1056(2022)
.Discussion on medication rules of national Chinese medicine master NAN Zheng in treating diabetic kidney disease of qi and yin deficiency and blood stasis syndrome based on data mining[J]. Beijing Journal of Traditional Chinese Medicine,2022,41(09):1053-1056.
.Discussion on medication rules of national Chinese medicine master NAN Zheng in treating diabetic kidney disease of qi and yin deficiency and blood stasis syndrome based on data mining[J]. Beijing Journal of Traditional Chinese Medicine,2022,41(09):1053-1056. DOI: 10.16025/j.1674-1307.2022.09.027.
Discussion on medication rules of national Chinese medicine master NAN Zheng in treating diabetic kidney disease of qi and yin deficiency and blood stasis syndrome based on data mining
GUO KF,ZHANG L,ZHAO FY,et al.Prevalence of chronic kidney disease and associated factors in Chinese individuals with type 2 diabetes:cross-sectional study[J].J Diabetes Complications,2016,30(5):803-810.
WANG YJ,HUANG SL,FENG Y,et al.Emodin,an 11β-hydroxysteroid dehydrogenase type 1 inhibitor,regulates adipocyte function in vitro and exerts anti-diabetic effect in ob/ob mice[J].Acta pharmacol Sin,2012,33(9):1195-1203.